BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

517 related articles for article (PubMed ID: 36982428)

  • 1. Biomarkers of Migraine: An Integrated Evaluation of Preclinical and Clinical Findings.
    Demartini C; Francavilla M; Zanaboni AM; Facchetti S; De Icco R; Martinelli D; Allena M; Greco R; Tassorelli C
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating Biomarkers in Migraine: New Opportunities for Precision Medicine.
    Ferroni P; Barbanti P; Spila A; Fratangeli F; Aurilia C; Fofi L; Egeo G; Guadagni F
    Curr Med Chem; 2019; 26(34):6191-6206. PubMed ID: 29932027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of calcitonin gene-related peptide function: a promising strategy for treating migraine.
    Durham PL
    Headache; 2008 Sep; 48(8):1269-75. PubMed ID: 18808507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new era for migraine: The role of calcitonin gene-related peptide in the trigeminovascular system.
    Chen ST; Wu JW
    Prog Brain Res; 2020; 255():123-142. PubMed ID: 33008504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcitonin gene-related peptide: an update on the biology.
    Recober A; Russo AF
    Curr Opin Neurol; 2009 Jun; 22(3):241-6. PubMed ID: 19434786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is calcitonin gene-related peptide a reliable biochemical marker of migraine?
    Tesfay B; Karlsson WK; Moreno RD; Hay DL; Hougaard A
    Curr Opin Neurol; 2022 Jun; 35(3):343-352. PubMed ID: 35674078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CGRP mechanism antagonists and migraine management.
    Karsan N; Goadsby PJ
    Curr Neurol Neurosci Rep; 2015 May; 15(5):25. PubMed ID: 25790955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CGRP as the target of new migraine therapies - successful translation from bench to clinic.
    Edvinsson L; Haanes KA; Warfvinge K; Krause DN
    Nat Rev Neurol; 2018 Jun; 14(6):338-350. PubMed ID: 29691490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcitonin gene-related peptide and migraine.
    Karsan N; Goadsby PJ
    Curr Opin Neurol; 2015 Jun; 28(3):250-4. PubMed ID: 25887765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Potentials of Uncariae Ramulus Cum Uncis for the Treatment of Migraine: Targeting CGRP in the Trigeminovascular System.
    Chong CM; Zhong Z; Vong CT; Wang S; Lu JJ; Zhong HJ; Su H; Wang Y
    Curr Neuropharmacol; 2021; 19(7):1090-1100. PubMed ID: 33121411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Towards precision medicine in migraine: Recent therapeutic advances and potential biomarkers to understand heterogeneity and treatment response.
    Juhasz G; Gecse K; Baksa D
    Pharmacol Ther; 2023 Oct; 250():108523. PubMed ID: 37657674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcitonin gene-related peptide (CGRP): role in migraine pathophysiology and therapeutic targeting.
    Wattiez AS; Sowers LP; Russo AF
    Expert Opin Ther Targets; 2020 Feb; 24(2):91-100. PubMed ID: 32003253
    [No Abstract]   [Full Text] [Related]  

  • 13. Gender aspects of CGRP in migraine.
    Labastida-Ramírez A; Rubio-Beltrán E; Villalón CM; MaassenVanDenBrink A
    Cephalalgia; 2019 Mar; 39(3):435-444. PubMed ID: 29082826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Migraine, Neurogenic Inflammation, Drug Development - Pharmacochemical Aspects.
    Lukacs M; Tajti J; Fulop F; Toldi J; Edvinsson L; Vecsei L
    Curr Med Chem; 2017; 24(33):3649-3665. PubMed ID: 28707585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting of calcitonin gene-related peptide action as a new strategy for migraine treatment.
    Kuzawińska O; Lis K; Cessak G; Mirowska-Guzel D; Bałkowiec-Iskra E
    Neurol Neurochir Pol; 2016; 50(6):463-467. PubMed ID: 27553188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CGRP and migraine: from bench to bedside.
    Edvinsson L
    Rev Neurol (Paris); 2021 Sep; 177(7):785-790. PubMed ID: 34275653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in targeting calcitonin gene-related peptide for the treatment of menstrual migraine: A narrative review.
    Jiang Y; Huang ZL
    Medicine (Baltimore); 2022 Jun; 101(24):e29361. PubMed ID: 35713436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Calcitonin gene-related peptide: a key player neuropeptide in migraine].
    Ramos-Romero ML; Sobrino-Mejia FE
    Rev Neurol; 2016 Nov; 63(10):460-468. PubMed ID: 27819404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibodies for migraine: preventing calcitonin gene-related peptide activity.
    Bigal ME; Walter S
    CNS Drugs; 2014 May; 28(5):389-99. PubMed ID: 24638916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcitonin gene-related peptide (CGRP) and migraine current understanding and state of development.
    Bigal ME; Walter S; Rapoport AM
    Headache; 2013 Sep; 53(8):1230-44. PubMed ID: 23848260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.